Refocus RFCS Stock
0 USD
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
United States
Exchange
OTC Markets OTCPK
Market Cap
0 USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
47.4K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Refocus Price Chart
Refocus RFCS Financial and Trading Overview
| Refocus stock price | 0.0000 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 71.57K USD |
| Avg. Volume | 40.78K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.240934 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RFCS Valuation Measures
| Enterprise Value | 2.08M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.47 |
Trading Information
Refocus Stock Price History
| Beta (5Y Monthly) | -0.240934 |
| 52-Week Change | -99.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 5.05E-5 USD |
| 200-Day Moving Average | 5.05E-5 USD |
RFCS Share Statistics
| Avg. Volume (3 month) | 40.78K USD |
| Avg. Daily Volume (10-Days) | 40.78K USD |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2004 |
| Most Recent Quarter (mrq) | September 30, 2005 |
| Next Fiscal Year End | December 31, 2005 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -88.087% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -4418863 USD |
| Net Income Avi to Common (ttm) | -4772489 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.08M USD |
| Total Cash Per Share (mrq) | 0.13 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.226 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4009553 USD |
| Levered Free Cash Flow (ttm) | -2458738 USD |
Profile of Refocus
| Country | United States |
| State | TX |
| City | Dallas |
| Address | 10210 North Central Expressway |
| ZIP | 75231 |
| Phone | 214-368-0200 |
| Website | https://www.refocus-group.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 4 |
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
Q&A For Refocus Stock
What is a current RFCS stock price?
Refocus RFCS stock price today per share is 0.0000 USD.
How to purchase Refocus stock?
You can buy RFCS shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Refocus?
The stock symbol or ticker of Refocus is RFCS.
How many shares does Refocus have in circulation?
The max supply of Refocus shares is 0.
What is Refocus Price to Earnings Ratio (PE Ratio)?
Refocus PE Ratio is now.
What was Refocus earnings per share over the trailing 12 months (TTM)?
Refocus EPS is 0 USD over the trailing 12 months.